UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer

The New England journal of medicine, 2016-12, Vol.375 (23), p.2255-2262

2016

Volltextzugriff (PDF)

Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression

Clinical cancer research, 2017-05, Vol.23 (10), p.2491-2505

2017

Volltextzugriff (PDF)

Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients

Nature communications, 2019-01, Vol.10 (1), p.449-449, Article 449

2019

Volltextzugriff (PDF)

Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer

Nature medicine, 2018-06, Vol.24 (6), p.724-730

2018

Volltextzugriff (PDF)

Identification and Clinical Application of Immunological Receptors Targeting Mutated Antigens Expressed by Solid Tumors

Cancers, 2020-10, Vol.12 (10), p.2818

Pasetto, Anna

2020

Volltextzugriff (PDF)

Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients

Nature medicine, 2016-04, Vol.22 (4), p.433-438

2016

Volltextzugriff (PDF)

Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer

Science (American Association for the Advancement of Science), 2017-04, Vol.356 (6334), p.200-205

2017

Volltextzugriff (PDF)

Single-Cell TCR and Transcriptome Analysis: An Indispensable Tool for Studying T-Cell Biology and Cancer Immunotherapy

Frontiers in immunology, 2021-06, Vol.12, p.689091-689091

2021

Volltextzugriff (PDF)

Liver, Tumor and Viral Hepatitis: Key Players in the Complex Balance Between Tolerance and Immune Activation

Frontiers in immunology, 2020-03, Vol.11, p.552-552

2020

Volltextzugriff (PDF)

Recognition of human gastrointestinal cancer neoantigens by circulating PD-1+ lymphocytes

The Journal of clinical investigation, 2019-11, Vol.129 (11), p.4992-5004

2019

Volltextzugriff (PDF)

Editorial: Personalized immunotherapy for cancer

Frontiers in oncology, 2023, Vol.13, p.1171907-1171907

2023

Volltextzugriff (PDF)

A Pilot Trial of the Combination of Vemurafenib with Adoptive Cell Therapy in Patients with Metastatic Melanoma

Clinical cancer research, 2017-01, Vol.23 (2), p.351-362

2017

Volltextzugriff (PDF)

T-Cell Receptor Repertoire Sequencing and Its Applications: Focus on Infectious Diseases and Cancer

International journal of molecular sciences, 2022-08, Vol.23 (15), p.8590

2022

Volltextzugriff (PDF)

Blocking Entry of Hepatitis B and D Viruses to Hepatocytes as a Novel Immunotherapy for Treating Chronic Infections

The Journal of infectious diseases, 2021-01, Vol.223 (1), p.128-138

2021

Volltextzugriff (PDF)

Liquid Biopsy in Hepatocellular Carcinoma: Opportunities and Challenges for Immunotherapy

Cancers, 2021-08, Vol.13 (17), p.4334

2021

Volltextzugriff (PDF)

Process Development for Adoptive Cell Therapy in Academia: A Pipeline for Clinical-Scale Manufacturing of Multiple TCR-T Cell Products

Frontiers in immunology, 2022-06, Vol.13, p.896242-896242

2022

Volltextzugriff (PDF)

PB2501: INSIGHT‐1: A PHASE I FIRST‐IN‐HUMAN TCR TRIAL OF GENETICALLY MODIFIED T‐CELLS TARGETING TDT IN CHILDREN AND ADULTS WITH T‐ AND B‐CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA (TRIAL‐IN‐PROGRESS)

HemaSphere, 2023-08, Vol.7 (S3), p.e06642c9-n/a

2023

Volltextzugriff (PDF)

Autologous anti-GD2 CAR T cells efficiently target primary human glioblastoma

NPJ precision oncology, 2024-02, Vol.8 (1), p.26-26, Article 26

2024

Volltextzugriff (PDF)

Chronic Viral Liver Diseases: Approaching the Liver Using T Cell Receptor-Mediated Gene Technologies

Cells (Basel, Switzerland), 2020-06, Vol.9 (6), p.1471

2020

Volltextzugriff (PDF)

The adjuvant activity of alphavirus replicons is enhanced by incorporating the microbial molecule flagellin into the replicon

PloS one, 2013-06, Vol.8 (6), p.e65964-e65964

2013

Volltextzugriff (PDF)

Use of CD137 up-regulation to identify T cell receptors specifically reactive with mutated tumor associated antigens from tumor infiltrating lymphocytes

Journal for immunotherapy of cancer, 2015-11, Vol.3 (Suppl 2), p.P40-P40, Article P40

2015

Volltextzugriff (PDF)

Identification of mutation-specific tumor infiltrating lymphocytes from metastatic ovarian cancer

Journal for immunotherapy of cancer, 2015-11, Vol.3 (Suppl 2), p.P10-P10, Article P10

2015

Volltextzugriff (PDF)

Adoptively transferred tumor-infiltrating T cells target somatic cancer mutations in a human papillomavirus+ cancer patient with complete tumor regression

Journal for immunotherapy of cancer, 2015-11, Vol.3 (Suppl 2), p.P52-P52, Article P52

2015

Volltextzugriff (PDF)

Tetramer based approach for efficient identification and isolation of neo-antigen specific CD8 T cells from peripheral blood (PBL) of patients with metastatic cancers

Journal for immunotherapy of cancer, 2015-11, Vol.3 (Suppl 2), p.P47-P47

2015

Volltextzugriff (PDF)

T-cell Responses to TP53 "Hotspot" Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers

Clinical cancer research, 2018-11, Vol.24 (22), p.5562-5573

2018

Volltextzugriff (PDF)

1 – 25 von 84

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(69)

Publikationsform

Sprache

Englisch
(79)
Italienisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer

Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression

Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients

Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer

Identification and Clinical Application of Immunological Receptors Targeting Mutated Antigens Expressed by Solid Tumors

Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients

Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer

Single-Cell TCR and Transcriptome Analysis: An Indispensable Tool for Studying T-Cell Biology and Cancer Immunotherapy

Liver, Tumor and Viral Hepatitis: Key Players in the Complex Balance Between Tolerance and Immune Activation

Recognition of human gastrointestinal cancer neoantigens by circulating PD-1+ lymphocytes

Editorial: Personalized immunotherapy for cancer

A Pilot Trial of the Combination of Vemurafenib with Adoptive Cell Therapy in Patients with Metastatic Melanoma

T-Cell Receptor Repertoire Sequencing and Its Applications: Focus on Infectious Diseases and Cancer

Blocking Entry of Hepatitis B and D Viruses to Hepatocytes as a Novel Immunotherapy for Treating Chronic Infections

Liquid Biopsy in Hepatocellular Carcinoma: Opportunities and Challenges for Immunotherapy

Process Development for Adoptive Cell Therapy in Academia: A Pipeline for Clinical-Scale Manufacturing of Multiple TCR-T Cell Products

PB2501: INSIGHT‐1: A PHASE I FIRST‐IN‐HUMAN TCR TRIAL OF GENETICALLY MODIFIED T‐CELLS TARGETING TDT IN CHILDREN AND ADULTS WITH T‐ AND B‐CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA (TRIAL‐IN‐PROGRESS)

Autologous anti-GD2 CAR T cells efficiently target primary human glioblastoma

Chronic Viral Liver Diseases: Approaching the Liver Using T Cell Receptor-Mediated Gene Technologies

The adjuvant activity of alphavirus replicons is enhanced by incorporating the microbial molecule flagellin into the replicon

Use of CD137 up-regulation to identify T cell receptors specifically reactive with mutated tumor associated antigens from tumor infiltrating lymphocytes

Identification of mutation-specific tumor infiltrating lymphocytes from metastatic ovarian cancer

Adoptively transferred tumor-infiltrating T cells target somatic cancer mutations in a human papillomavirus+ cancer patient with complete tumor regression

Tetramer based approach for efficient identification and isolation of neo-antigen specific CD8 T cells from peripheral blood (PBL) of patients with metastatic cancers

T-cell Responses to TP53 "Hotspot" Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers

Suchergebnisse filtern